Article
Immunology
Miho Shibamura-Fujiogi, Koichi Yuki, Lifei Hou
Summary: Through bone marrow chimeras, researchers found that CtsL is involved in the pathogenicity of CD4 T cells in autoimmune diseases, but there is no defect in differentiation in vitro. In the experimental autoimmune encephalomyelitis (EAE) model, deficiency of CtsL significantly decreased the activation of pathogenic CD4 T cells.
INTERNATIONAL IMMUNOPHARMACOLOGY
(2021)
Article
Biotechnology & Applied Microbiology
Junying Chen, Jinbing Huang, Qiaoqiao Huang, Ji Li, Erling Chen, Wensheng Xu
Summary: In cervical squamous cell carcinoma, the low expression of RASA4 is associated with high prognostic and diagnostic values. RASA4 inhibits the proliferation of cervical cancer cells by inactivating the HIFα signaling pathway, suggesting potential prospects for targeted therapy.
Article
Multidisciplinary Sciences
Weiwei Tie, Fenfen Ge
Summary: This study investigated the role of lymphoid-specific helicase (HELLS) in cervical cancer and found that its overexpression promotes cell proliferation and inhibits cell death. The suppression of Nrf2 expression by HELLS may contribute to cervical cancer progression. HELLS knockdown could be effective in treating cervical cancer.
Article
Biochemistry & Molecular Biology
Lei Yuan, Juanping Zhao, Songkun Zhao, Tianyi Dong, Ruitong Dong, Dongyue Liu, Enlong Ma, Yanchun Li
Summary: This study synthesized a novel CATs inhibitor, ASPER-29, and demonstrated its ability to block the metastasis of pancreatic cancer cells by inhibiting the activity of CAT-L and CAT-S.
CHEMICO-BIOLOGICAL INTERACTIONS
(2022)
Article
Cell Biology
Chen Wang, Jie Zeng, Li-Jie Li, Min Xue, Si-Li He
Summary: The study showed that Cdc25A regulates ferroptosis in cervical cancer cells by modulating the levels of PKM2 and ErbB2, affecting the response of cervical cancer cells to sorafenib treatment.
CELL DEATH & DISEASE
(2021)
Article
Oncology
Marloes IJff, Gregor G. W. van Bochove, Denise Whitton, Roy Winiarczyk, Celina Honhoff, Hans Rodermond, Johannes Crezee, Lukas J. A. Stalpers, Nicolaas A. P. Franken, Arlene L. Oei
Summary: The five-year survival rates for patients with locally advanced cervical cancer range from 40% to 60%. Chemoradiation or thermoradiation is commonly used to treat these patients. This study aimed to enhance these conventional therapies by adding a PARP1-inhibitor, which sensitizes cervical cancer cells to treatment. The results showed that adding PARP1-i to chemoradiation or thermoradiation resulted in lower survival fractions and increased unrepaired DNA double-strand breaks (DSBs).
Article
Oncology
Yuanfeng Gou, Fei Li, Xiaqin Huo, Chunyan Hao, Xiaojuan Yang, Yaping Pei, Na Li, Huiling Liu, Bingdong Zhu
Summary: ENO1mAb has been shown to specifically block ENO1 expressed on cell membranes and inhibit its glycolysis enzyme activity inside tumor cells, demonstrating promising anti-tumor effects against cervical cancer cells.
AMERICAN JOURNAL OF CANCER RESEARCH
(2021)
Article
Pharmacology & Pharmacy
Qin Wang, Ying-Tzu Yen, Chen Xie, Fangcen Liu, Qin Liu, Jia Wei, Lixia Yu, Lifeng Wang, Fanyan Meng, Rutian Li, Baorui Liu
Summary: The study demonstrates that using gelatinase-stimuli nanoparticles loaded with Sal-Docetaxel can simultaneously inhibit tumor stem cells and non-stem cells, enhance anti-tumor efficacy, and reduce side effects.
Article
Multidisciplinary Sciences
Xiaodong Sun, Hongxia Xu, Tianyu Dai, Lixia Xie, Qiang Zhao, Xincai Hao, Yan Sun, Xuanbin Wang, Nan Jiang, Ming Sang
Summary: This study highlights the significant role of BMI1 in cervical cancer, with high expression associated with poor differentiation, high clinical grade, and poor prognosis. Furthermore, alantolactone shows promising effects in reducing proliferation, migration, and invasion of cervical cancer cells, as well as promoting autophagy and mitochondrial damage.
SCIENTIFIC REPORTS
(2021)
Article
Oncology
Nathan T. Givens, Lei Zhao, Ziwen Zhu, Marco Lequio, Huaping Xiao, Bradley D. Johnson, Qian Bai, Mark R. Wakefield, Yujiang Fang
Summary: This study found that mangosteen extract (ME) inhibits the growth and proliferation of SiHa cervical cancer cells and induces apoptosis. This anti-proliferative and pro-apoptotic effect may be associated with the down-regulation of cyclin B, cyclin D, cyclin E, as well as FLIP and survivin. Therefore, ME may be a promising strategy for targeted cancer immunotherapy development.
ANTICANCER RESEARCH
(2022)
Article
Chemistry, Multidisciplinary
Rajmohamed Mohammed Asik, Chidhambaram Manikkaraja, Karuppusamy Tamil Surya, Natarajan Suganthy, Archunan Priya Aarthy, Domokos Mathe, Muthusamy Sivakumar, Govindaraju Archunan, Parasuraman Padmanabhan, Balazs Gulyas
Summary: This study synthesized silver nanoparticles using L-histidine and characterized them through spectroscopic and microscopic studies. The results showed that the nanoparticles have potential in inhibiting cervical cancer cells, making them promising candidates for cervical cancer therapy.
Article
Oncology
Alex Federico, Luigi Pedone Anchora, Valerio Gallotta, Francesco Fanfani, Francesco Cosentino, Luigi Carlo Turco, Nicolo' Bizzarri, Francesco Legge, Elena Teodorico, Gabriella Macchia, Vincenzo Valentini, Giovanni Scambia, Gabriella Ferrandina
Summary: Persistence of pathologic residual tumor on the cervix and lymph nodes after chemoradiation and adjuvant surgery is a reliable predictor of survival for locally advanced cervical cancer patients. Positive pelvic lymph nodes and aortic lymph nodes are also associated with worse survival rates.
ANNALS OF SURGICAL ONCOLOGY
(2022)
Article
Chemistry, Medicinal
Haoqiang Huang, Yi Zhang, Xiaohong Xu, Yongzheng Liu, Juanping Zhao, Lili Ma, Jie Lei, Wentao Ge, Ning Li, Enlong Ma, Yanchun Li, Lei Yuan
Summary: Currently, the migration and invasion of cancer cells remain the main factors of poor prognosis in the majority of cancer patients. Developing an effective antimetastatic agent is crucial for cancer therapy. Our recent research revealed that a compound B1a derived from asperphenamate showed the strongest inhibitory activity against Cat L and S in metastatic pancreatic cancer cells, indicating its potential as an antimetastatic agent.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2023)
Article
Chemistry, Medicinal
Jiajun Ni, Hualin Feng, Xiang Xu, Tingting Liu, Ting Ye, Kan Chen, Gongchu Li
Summary: The study found that AVL enhances the anti-growth effect of oncoVV on cervical cancer cells by promoting virus replication and activating relevant proteins.
Article
Microbiology
Fei Yu, Ting Pan, Feng Huang, Ruosu Ying, Jun Liu, Huimin Fan, Junsong Zhang, Weiwei Liu, Yingtong Lin, Yaochang Yuan, Tao Yang, Rong Li, Xu Zhang, Xi Lv, Qianyu Chen, Anqi Liang, Fan Zou, Bingfeng Liu, Fengyu Hu, Xiaoping Tang, Linghua Li, Kai Deng, Xin He, Hui Zhang, Yiwen Zhang, Xiancai Ma
Summary: The outbreak of COVID-19 has posed a serious threat to global public health. Finding effective treatments is crucial but hindered by limited understanding of the virus and lack of specific antiviral agents. This study reveals that teicoplanin can inhibit the cell entry of SARS-CoV-2 and prevent cellular infection. Teicoplanin shows potential as a universal intervention against coronaviruses.
FRONTIERS IN MICROBIOLOGY
(2022)
Article
Oncology
Neal Andruska, Benjamin W. Fischer-Valuck, Temitope Agabalogun, Ruben Carmona, Randall J. Brenneman, Yi Huang, Hiram A. Gay, Jeff M. Michalski, Brian C. Baumann
Summary: In patients with unfavorable intermediate-risk prostate cancer, the use of SBRT was associated with significantly longer survival compared to longer courses of radiotherapy. This study provides support for the use of SBRT in this patient population.
CLINICAL GENITOURINARY CANCER
(2022)
Article
Multidisciplinary Sciences
Huiyan Huang, Jiehong Pan, David R. Spielberg, Neil A. Hanchard, Daryl A. Scott, Lindsay C. Burrage, Hongzheng Dai, David Murdock, Jill A. Rosenfeld, Ariz Mohammad, Tao Huang, Anika G. Lindsey, Hyori Kim, Jian Chen, Avinash Ramu, Stephanie A. Morrison, Zachary D. Dawson, Alex Z. Hu, Eric Tycksen, Gary A. Silverman, Dustin Baldridge, Jennifer A. Wambach, Stephen C. Pak, Steven L. Brody, Tim Schedl
Summary: The study identified a mutation in RAB5B p.Asp136His as a genetic mechanism for surfactant dysfunction disorder. Functional and genetic analysis revealed that this mutation causes defects in the processing and trafficking of surfactant proteins, leading to interstitial lung disease.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
(2022)
Article
Oncology
Sai Duriseti, James A. Kavanaugh, Jeff Szymanski, Yi Huang, Franco Basarabescu, Aadel Chaudhuri, Lauren Henke, Pamela Samson, Alexander Lin, Clifford Robinson, Matthew B. Spraker
Summary: This study evaluated the acute toxicity and quality of life of patients with large tumors treated with Lattice SBRT. The results showed no significant treatment-related severe toxicity in the 90-day period, but there was one case of severe toxicity possibly associated with Lattice SBRT.
RADIOTHERAPY AND ONCOLOGY
(2022)
Article
Oncology
Nishanth Gabriel, Kumaresh Balaji, Kay Jayachandran, Matthew Inkman, Jin Zhang, Sonika Dahiya, Michael Goldstein
Summary: This study explores the role of EZH2-dependent histone H3K27 trimethylation in radiotherapy response in medulloblastoma and identifies the association between H3K27me3 deficiency and radioresistance in medulloblastoma.
Article
Oncology
Andrew Nickless, Jin Zhang, Ghofran Othoum, Jace Webster, Matthew J. Inkman, Emily Coonrod, Sherron Fontes, Emily B. Rozycki, Christopher A. Maher, Nicole M. White
MOLECULAR CANCER RESEARCH
(2022)
Article
Biochemistry & Molecular Biology
Jill Alldredge, Vinay Kumar, James Nguyen, Brooke E. Sanders, Karina Gomez, Kay Jayachandran, Jin Zhang, Julie Schwarz, Farah Rahmatpanah
Summary: Using RNA-seq data from cervical cancer patients, the expression of endogenous human retroviruses (ERVs) in cervical cancers was investigated. Significant differences in ERVs expression were found among different racial subgroups, HPV subtypes, tumor stages, and patient survival. Combining ERV expression with clinical factors improved prognostication compared to clinical factors alone.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Cell Biology
Subhajit Ghosh, Jiayi Huang, Matthew Inkman, Jin Zhang, Sukrutha Thotala, Ekaterina Tikhonova, Natalia Miheecheva, Felix Frenkel, Ravshan Ataullakhanov, Xiaowei Wang, David DeNardo, Dennis Hallahan, Dinesh Thotala
Summary: Severe and prolonged lymphopenia often occurs in glioblastoma patients after standard chemoradiotherapy, and it is associated with worse survival. A correlative study was conducted on 20 patients with glioblastoma to investigate the underlying biological mechanism of lymphopenia. The study revealed an elevated concentration of myeloid-derived suppressor cell (MDSC) regulatory genes in patients with lymphopenia after chemoradiotherapy. Further analysis confirmed increased numbers of circulating MDSC in these patients, and preclinical models demonstrated a causal relationship between radiation-induced MDSC and systemic lymphopenia. Pharmacological inhibition of MDSC effectively prevented radiation-induced lymphopenia and improved survival in the models, suggesting the potential of CB1158 and tadalafil as drugs for reducing lymphopenia in glioblastoma patients.
SCIENCE TRANSLATIONAL MEDICINE
(2023)
Article
Oncology
Douglas Faget, Xianmin Luo, Matthew J. Inkman, Qihao Ren, Xinming Su, Kai Ding, Michael R. Waters, Ganesh Kumar Raut, Gaurav Pandey, Paarth B. Dodhiawala, Renata Ramalho-Oliveira, Jiayu Ye, Thomas Cole, Bhavna Murali, Alexander Zheleznyak, Monica Shokeen, Kurt R. Weiss, Joseph B. Monahan, Carl J. Deslm, Adrian V. Lee, Steffi Oesterreich, Katherine N. Weilbaecher, Jin Zhang, David G. DeNardo, Sheila A. Stewart
Summary: We found that p38MAPKα inhibition can limit tumor growth by reprogramming the metastatic tumor microenvironment. By identifying targets that further increase p38i efficacy, we demonstrated that combination therapy with p38i and an OX40 agonist can synergistically reduce metastatic growth and increase overall survival. Our findings highlight the importance of understanding the tumor stromal compartment in therapeutic design.
Article
Hematology
Alexander B. Kim, Ssu-Yu Chou, Solomon Kang, Eric Kwon, Matthew Inkman, Jeff Szymanski, Neal Andruska, Cian Colgan, Jin Zhang, Joanna C. Yang, Nathan Singh, Carl J. Deselm
Summary: Chimeric antigen receptor (CAR) T-cell therapy is a significant breakthrough for hematologic malignancies, but majority of patients still die from the disease. Tumor quantity and quality are predictors of response, with higher disease burden and intrinsic tumor resistance leading to worse prognosis. High-dose radiation to bulky disease areas reduces systemic tumor quantity, but low-dose total tumor irradiation (TTI) targeting all disease sites before CAR T-cell therapy has a greater impact on overall survival in mice. This study suggests that intrinsic tumor attributes are equally or more important predictors of CAR T-cell response as tumor burden, and low-dose TTI can temporarily increase tumor sensitivity to CAR T cells.
Article
Biochemistry & Molecular Biology
Klaas Koop, Weimin Yuan, Federico Tessadori, Wilmer R. Rodriguez-Polanco, Jeremy Grubbs, Bo Zhang, Matt Osmond, Gail Graham, Sarah Sawyer, Erin Conboy, Francesco Vetrini, Kayla Treat, Rafal Ploski, Victor Murcia Pienkowski, Anna Klosowska, Elizabeth Fieg, Joel Krier, Coralie Mallebranche, Ziegler Alban, Kimberly A. Aldinger, Deborah Ritter, Ellen Macnamara, Bonnie Sullivan, John Herriges, Joseph T. Alaimo, Catherine Helbig, Colin A. Ellis, Clare van Eyk, Jozef Gecz, Daniel Farrugia, Ikeoluwa Osei-Owusu, Lesley Ades, Marie-Jose van den Boogaard, Sabine Fuchs, Jeroen Bakker, Karen Duran, Zachary D. Dawson, Anika Lindsey, Huiyan Huang, Dustin Baldridge, Gary A. Silverman, Barth D. Grant, David Raizen, Gijs van Haaften, Stephen C. Pak, Holger Rehmann, Tim Schedl, Peter van Hasselt
Summary: RAB5C gene mutations are associated with neurodevelopmental disorders characterized by macrocephaly and mild-to-moderate developmental delay, through disruption of the endocytic pathway.
HUMAN MOLECULAR GENETICS
(2023)
Article
Biology
Emilee N. Kotnik, Mary M. Mullen, Nicholas C. Spies, Tiandao Li, Matthew Inkman, Jin Zhang, Fernanda Martins-Rodrigues, Ian S. Hagemann, Carolyn K. McCourt, Premal H. Thaker, Andrea R. Hagemann, Matthew A. Powell, David G. Mutch, Dineo Khabele, Gregory D. Longmore, Elaine R. Mardis, Christopher A. Maher, Christopher A. Miller, Katherine C. Fuh
Summary: Analysis of genomic and transcriptomic alterations in primary and metastatic tumors of high-grade serous ovarian cancer patients reveals differences associated with survival outcomes, providing insights for personalized treatment options and drug development.
COMMUNICATIONS BIOLOGY
(2023)